| Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 21st, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 21st, 2024 04:14PM | Apr 21st, 2024 04:14PM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 20th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 20th, 2024 04:29PM | Apr 20th, 2024 04:29PM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 19th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 19th, 2024 07:26AM | Apr 19th, 2024 07:26AM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 18th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 18th, 2024 05:48PM | Apr 18th, 2024 05:48PM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 17th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 17th, 2024 02:16PM | Apr 17th, 2024 02:16PM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 16th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 16th, 2024 10:26AM | Apr 16th, 2024 10:26AM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 15th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 15th, 2024 04:49PM | Apr 15th, 2024 04:49PM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 14th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 14th, 2024 10:28AM | Apr 14th, 2024 10:28AM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 13th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 13th, 2024 10:56AM | Apr 13th, 2024 10:56AM | Axovant Sciences | |||||||||||||||||
| nasdaq:axon | https://www.glassdoor.com?employer_id=1397238 | 1397238 | Apr 12th, 2024 12:00AM | Open | Axovant Sciences | Open | Company - Public | Biotech & Pharmaceuticals | London, United Kingdom | 2014 | 3.10 | -100% | 0% | 0% | 3.70 | 1.90 | 2.70 | 2.50 | 3.20 | 2.10 | 1.00 | 1.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 | 25% | 25% | 25% | 25% | 0.00 | 0.00 | 7.00 | 1.00 | 1.00 | Pavan Cheruvu | Apr 12th, 2024 07:49AM | Apr 12th, 2024 07:49AM | Axovant Sciences |